Condition
Hip Osteoarthritis
Substantially less data than the knee.
Quick summary
- • Mostly uncontrolled studies
Overview
Hip osteoarthritis has well-defined standard care, so SVF research remains exploratory.
Mechanisms studied
Similar to the knee.
Human research
HHS and VAS reported in small cohorts.
Safety
Reported adverse events are mostly local — swelling, pain, or bruising at the harvest and injection sites. Infection and cell-processing quality remain the key risks to monitor.
Evidence limitations
Existing studies are limited by sample size, methodology, and follow-up, and SVF preparation differs substantially between centres, making cross-study comparison difficult.
Related research
- Level CProspective Study
Clinical use of autologous adipose-derived stromal vascular fraction cell injections for hip osteoarthritis
42 hip osteoarthritis patients received a single intra-articular injection averaging 3.8 × 10⁷ SVF cells, with at least six months of follow-up.
- 2023
- Japan
- n = 42
- Level DRetrospective Study
A Retrospective Study of Stromal Vascular Fraction Cell Therapy for Osteoarthritis
Chart review of 350 knee and hip osteoarthritis patients treated with autologous SVF between 2015 and 2018, reporting the proportion with improved pain and mobility.
- 2020
- Slovakia
- n = 350
Latest PubMed research
34 indexed studies for this condition · auto-updated 17 August 2026
- Level AMeta-analysisEurope PMC
The Efficacy of Bone Marrow Stem Cell Therapy in Hip Osteoarthritis: A Scoping Review
Meta-analysis with a reported sample of 72 on Osteoarthritis, Hip Osteoarthritis, published in HSS J (2025) — summary generated from the PubMed abstract.
- 2025
- n = 72
HSS J2 citations - Level ASystematic ReviewPubMed
Outcomes Following Stem Cell-Based Therapies for Hip Osteoarthritis: A Scoping Review.
Systematic Review on Osteoarthritis, Cartilage Damage, Hip Osteoarthritis, Chronic Inflammation, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus - Level ASystematic ReviewPubMed
Orthobiologic injections for hip osteoarthritis: A systematic review of clinical outcomes.
Systematic Review with a reported sample of 36 on Osteoarthritis, Hip Osteoarthritis, published in Orthop Rev (Pavia) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 36
Orthop Rev (Pavia) - Level ASystematic ReviewPubMed
Safety and Efficacy of Bone-Marrow Aspirate Concentrate in Hip Osteoarthritis: A Systematic Review of Current Clinical Evidence.
Systematic Review on Osteoarthritis, Hip Osteoarthritis, published in Indian J Orthop (2024) — summary generated from the PubMed abstract.
- 2024
Indian J Orthop2 citations - Level ASystematic ReviewEurope PMC
Management of hip osteoarthritis: harnessing the potential of mesenchymal stem cells-a systematic review
Systematic Review with a reported sample of 316 on Osteoarthritis, Cartilage Damage, Hip Osteoarthritis, published in Eur J Orthop Surg Traumatol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 316
Eur J Orthop Surg Traumatol2 citations - Level AMeta-analysisEurope PMC
Is there a genetic relationship between blood glucose and osteoarthritis? A mendelian randomization study
Meta-analysis on Knee Osteoarthritis, Osteoarthritis, Hip Osteoarthritis, published in Diabetol Metab Syndr (2024) — summary generated from the PubMed abstract.
- 2024
Diabetol Metab Syndr2 citations
Last updated: 2026-06-18 · arisa-w